Broad clinical research capabilities across phases, study types and indications
Our capabilities span a wide range of therapeutic areas and study types, supporting sponsors and CROs across Phase I–IV clinical development, including pharmacokinetic and observational research. We deliver studies with a focus on consistency, efficiency and quality across diverse protocol requirements.
Our site at a glance
years of site experience
commercial studies
sponsors partnered with
CROs worked with
critical audit findings
participant database
Therapeutic areas and expertise
Cardiovascular conditions
Ear, nose and throat related diseases
Endocrinology / metabolic disorders
Gastrointestinal diseases
Infectious disease
Musculoskeletal conditions
Nephrology and renal disease
Neurological diseases
Respiratory diseases
Women's health
Additional expertise
Complementary medicines
GMO trials
Pharmacokinetic investigations
Rare diseases
Technology and device trials
Vaccine development
Want to see our track record?
Explore our clinical trial portfolio to see the breadth of studies we have successfully delivered
Efficient, end-to-end study delivery
Our study delivery model is built to support efficiency, responsiveness and consistent performance across a diverse range of protocols. With a dedicated start-up team, established regulatory pathways and the ability to run key activities in parallel, we support rapid study activation and streamlined execution from feasibility through to closeout.
We maintain strong enrolment performance through diverse and well-established recruitment pathways, including a database of more than 6,000 participants, clinician referrals across public and private networks, university and community engagement, and multi-channel outreach.
Delivery is further supported by an experienced multidisciplinary team, integrated on-site pharmacy and laboratory capabilities, and a proactive, quality-focused approach to study conduct-ensuring reliable data, participant safety and a consistently high standard of execution across all studies.
Vibrant clinical research ecosystem
We are located within a vibrant and expanding Health and Knowledge Precinct on the Gold Coast, alongside two major hospitals, world-class university research centres, and a growing community of start-ups. The Gold Coast is home to Australia's fastest-growing economy and one of the fastest-growing populations, providing access to a large and diverse participant pool.
A trusted and highly recommended site partner.
 Over the past five years, Sanofi has partnered with GU CTU across multiple clinical studies spanning vaccines and translational research. [They have] demonstrated consistent delivery, exceptional quality, and a proactive, solutions focused approach that has made them a trusted and highly recommended site partner. Their ability to mobilise quickly, recruit effectively, and uphold the highest standards of clinical trial conduct has been outstanding. GU CTU is widely regarded as a leader in clinical research within the region, and their commitment to operational excellence has played a key role in enabling successful study execution.
Jolien Reid, Head of Clinical Operations, Sanofi